| NT pro-BNP 3000-10000 pg/mL ( group A, n = 108) | NT pro-BNP ≥10000 pg/mL (group B, n = 44) | P |
---|---|---|---|
Age (years) | 83.57 ± 3.33 | 83.84 ± 4.18 | 0.679 |
Male, n (%) | 66 (61.1) | 25 (56.8) | 0.625 |
BMI (kg/m2) | 22.64 ± 3.79 | 21.50 ± 3.33 | 0.084 |
SBP(mm Hg) | 126.69 ± 20.21 | 128.39 ± 23.19 | 0.653 |
DBP (mm Hg) | 68.25 ± 12.37 | 66.32 ± 16.54 | 0.487 |
Underlying commodities disease, n (%) | Â | Â | Â |
Coronary artery disease | 89(82.4) | 37(84.1) | 0.803 |
Atrial fibrillation | 43(39.8) | 15(84.1) | 0.447 |
Diabetes mellitus | 37(34.3) | 19(43.2) | 0.303 |
Hypertension | 81(75.0) | 36(81.8) | 0.367 |
COPD | 13(12.0) | 4(99.1) | 0.602 |
Respiratory failure | 13(12.0) | 7(15.9) | 0.523 |
Cancer | 29(26.9) | 10(22.7) | 0.860 |
Liver disease | 10(9.3) | 5(11.4) | 0.694 |
MODS | 6(5.6) | 1(2.3) | 0.383 |
Impaired renal function | 39(36.1) | 25(56.8) | 0.019 |
Infection | 57(52.8) | 28(63.6) | 0.223 |
Acute myocardial infarction | 7(6.5) | 4(9.1) | 0.951 |
Death | 9(8.3) | 15(34.1) | <0.001 |
Echocardiographic parameters | Â | Â | Â |
LVEF (%) | 54.88 ± 10.44 | 53.41 ± 9.98 | 0.427 |
Left atrial diameter (mm) | 39.39 ± 6.43 | 38.07 ± 5.34 | 0.231 |
Right atrial diameter (mm) | 37.81 ± 6.85 | 36.39 ± 5.22 | 0.216 |
Interventricular septum (mm) | 10.69 ± 1.57 | 10.80 ± 1.75 | 0.729 |
Posterior wall (mm) | 10.06 ± 1.28 | 10.14 ± 1.75 | 0.753 |
LV diastolic dimension (mm) | 49.98 ± 6.51 | 50.55 ± 5.42 | 0.613 |
LV systolic dimension (mm) | 35.67 ± 6.41 | 35.93 ± 5.74 | 0.265 |
Fractional shortening (%) | 29.81 ± 5.72 | 29.20 ± 4.79 | 0.297 |
Laboratory data | Â | Â | Â |
Creatinine (mg/dL) | 1.24(0.92-1.82) | 1.39(0.91-4.57) | 0.001 |
CK-MB (ng/dL) | 2.5(0.90-368) | 3.63(1.72-5.77) | 0.023 |
Serum albumin(g/dL) | 33.44 ± 5.11 | 32.83 ± 6.76 | 0.540 |
C-reactive protein (mg/dL) | 3.07(0.86-7.58) | 3.44(1.025-8.6) | 0.375 |
Medication, n (%) | Â | Â | Â |
ACEIs or ARBs | 7 (6.5) | 20 (45.5) | 0.803 |
β-blockers | 16(36.4) | 48(44.4) | 0.362 |